Riskpilot← Back to searchSign inGet full accessMEDIDYNE AS
ASActiveOrg 990752354Hovfaret 13, 0275 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20076 employees
Revenue 2025
NOK 84,4M
+23% vs 2024
EBITDA margin
11.0%
+17% vs 2024
Equity ratio
36.3%
Financial strength
Net profit 2025
NOK 6,8M
+2% vs 2024
| Revenue | NOK 84,4M | +23% |
| EBITDA | NOK 9,3M | +17% |
| Net profit | NOK 6,8M | +2% |
| Total assets | NOK 36,4M | +44% |
| Equity | NOK 13,2M | -1% |
| Employees | 6 | — |
Legal name
MEDIDYNE AS
Org number
990752354
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. januar 2007
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Daglig leder alene.
Company purpose
Drive kjøp og salg av medisinsk utstyr og sykepleierartikler og annen virksomhet som hører naturlig under dette.
Address
Hovfaret 13, 0275 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 142 751 | 136 638 | 69 629 | 68 577 | 84 417 |
| Staff expenses | −9 516 | −8 978 | −7 622 | −7 978 | −10 016 |
| EBITDA | 27 990 | 15 550 | 8 945 | 7 973 | 9 318 |
| Depreciation & amort. | −37 | −111 | −144 | −140 | −140 |
| EBIT | 27 953 | 15 439 | 8 801 | 7 832 | 9 177 |
| Net financials | 3 738 | 751 | −1 015 | 827 | −378 |
| Profit before tax | 31 691 | 16 190 | 7 786 | 8 659 | 8 799 |
| Tax | 6 974 | 3 563 | 1 713 | 1 914 | 1 952 |
| Net profit | 24 716 | 12 627 | 6 073 | 6 745 | 6 847 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 64 645 | 35 707 | 24 772 | 25 231 | 36 426 |
| Equity | 19 914 | 17 541 | 6 614 | 13 359 | 13 206 |
| Long-term debt | 9 | 13 | 4 | 0 | 0 |
| Short-term debt | 44 721 | 18 152 | 18 154 | 11 871 | 23 220 |
| Total debt | 44 730 | 18 165 | 18 157 | 11 871 | 23 220 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20212025
Equity ratio
36.3%
This company
38.2%
Market median
+5% vs market
20212025
Return on equity
51.8%
This company
18.4%
Market median
+182% vs market
20212025
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
20212025
Asset turnover
2.32×
This company
1.12×
Market median
+107% vs market
20212025
Debt / equity
1.76×
This company
0.62×
Market median
-184% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FW Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2014 | |
| Board of Directors | 2014 | |
| Former (1) | ||
| Board of Directors | 2014 – 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hjertevagt Holding Aps | Company | 92% | 92% | 2024 |
Ml Holding Ab | Company | 8% | 8% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIDYNE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frederik Werring Clem | Chief Executive Officer | 0 companies |
| Knut Werring Clem | Chairman | 0 companies |
| Nina Gjessing-Bakken | Board of Directors | 0 companies |
| Anders Mikael Lidén | Board of Directors | 0 companies |